Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transforming growth factor beta (TGF-beta) and autoimmunity.

Christopher A Aoki1, Andrea T Borchers, Ming Li

  • 1Division of Gastroenterology, Department of Internal Medicine, University of California Davis, Davis, CA 95616, United States.

Autoimmunity Reviews
|September 3, 2005
PubMed
Summary

Transforming growth factor-beta1 (TGF-beta1) deficiency in mice causes autoimmune disease, offering insights into human autoimmunity. This research explores TGF-beta

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long-Term Safety Extension.

Alimentary pharmacology & therapeutics·2026
Same author

Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective.

The American journal of gastroenterology·2026
Same author

Author Response to "Comment on Prediagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis".

Journal of gastroenterology and hepatology·2026
Same author

Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.

Hepatology communications·2026
Same author

Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Clover Honey Limits Survival of Enterotoxigenic Escherichia coli in an In Vitro Gastric Model and Reduces In Vitro Fermentation pH of Small Intestine Microbes.

The Journal of nutrition·2026

Area of Science:

  • Immunology
  • Autoimmunity Research
  • Molecular Biology

Background:

  • Transforming growth factor-beta1 (TGF-beta1) deficient mice exhibit multifocal inflammatory autoimmune disease.
  • This animal model is crucial for studying autoimmunity's etiology.
  • TGF-beta signaling plays a key role in immune system regulation.

Purpose of the Study:

  • To investigate the cell lineage-specific effects of TGF-beta on immune responses.
  • To elucidate the mechanisms by which TGF-beta deficiency contributes to autoimmune disease.
  • To understand the role of TGF-beta in mucosal immunity and inflammatory bowel disease pathogenesis.

Main Methods:

  • Utilizing transgenic mice expressing a dominant-negative form of TGF-beta receptor type II in T cells.

Related Experiment Videos

  • Analyzing immunological phenomena influenced by TGF-beta deficiency.
  • Examining effects on lymphocyte activation, differentiation, cell adhesion, regulatory T cell function, MHC expression, cytokines, and apoptosis.

    • Main Results:

    • TGF-beta deficiency impacts lymphocyte activation, differentiation, and apoptosis.
    • Altered expression of cell adhesion molecules and MHC molecules was observed.
    • Regulatory T cell function and cytokine profiles are significantly affected.
    • Mucosal immunity is particularly sensitive to TGF-beta's influence.

    Conclusions:

    • TGF-beta deficiency is a significant factor in the development of autoimmune diseases.
    • Dysregulation of immune cell functions by TGF-beta deficiency contributes to autoimmunity.
    • TGF-beta signaling is critical for maintaining mucosal immune homeostasis and preventing inflammatory bowel disease.